Roger Mize
Internal Medicine · Elberton, GANPI 1265439574
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 297 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 15.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,711 and has fallen 99.2% since, to $14 in 2025.
Across 297 payments — averaging $16.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$752
- AbbVie$558
- Novo Nordisk$486
- AstraZeneca$305
- Novartis$282
- Boehringer Ingelheim$262
- plus $2K from 30 others
What the payments were for
- Food & beverage$4,840100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 3 | $752 |
| AbbVie | 39 | $558 |
| Novo Nordisk | 55 | $486 |
| AstraZeneca | 23 | $305 |
| Novartis | 19 | $282 |
| Boehringer Ingelheim | 17 | $262 |
| Sanofi-aventis U.S. LLC | 14 | $240 |
| Pfizer | 18 | $204 |
| GSK | 12 | $196 |
| Johnson & Johnson | 12 | $170 |
| Astellas Pharma US Inc | 8 | $157 |
| Bayer | 8 | $121 |
| Amgen | 7 | $120 |
| Lilly USA, LLC | 9 | $120 |
| Teva Pharmaceuticals USA, Inc. | 8 | $117 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $90 |
| Kowa Pharmaceuticals America, Inc. | 6 | $80 |
| Otsuka America Pharmaceutical, Inc. | 3 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $57 |
| Merck | 4 | $55 |
| Nestle Healthcare Nutrition Inc. | 4 | $54 |
| Biogen | 3 | $45 |
| Corcept Therapeutics | 2 | $39 |
| Esperion Therapeutics, Inc. | 2 | $38 |
| E.r. Squibb & Sons, L.L.C. | 2 | $33 |
| Dexcom, Inc. | 2 | $30 |
| Exact Sciences | 1 | $24 |
| Lundbeck LLC | 1 | $24 |
| Genentech USA, Inc. | 1 | $21 |
| Medtronic | 1 | $18 |
| Amarin Pharma, Inc. | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Hikma Pharmaceuticals USA | 1 | $15 |
| Eyevance Pharmaceuticals LLC | 1 | $15 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $13 |
| Eisai Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,845 in reported general payments places this provider in the 85th percentile of 3,311 internal medicine providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Colchicine | 11 | $897 |
| Gabapentin | 32 | $770 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 21 | $511 |
| Levothyroxine Sodium | 51 | $442 |
| Glipizide ErGlipizide | 31 | $344 |
| Hydralazine Hcl | 12 | $326 |
| Simvastatin | 60 | $317 |
| Potassium Chloride | 17 | $288 |
| Pravastatin Sodium | 13 | $282 |
| Fluticasone Propionate | 23 | $258 |
| Atorvastatin Calcium | 27 | $255 |
| Omeprazole | 24 | $244 |
| Amlodipine Besylate | 65 | $228 |
| Allopurinol | 25 | $217 |
| Benazepril Hcl | 14 | $206 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Elberton
- Michael GibsonSmyrna$2.2M
- Eduard FatakhovAlpharetta$376K
- Tracey HenryAtlanta$305K
- Sharon TuckettVilla Rica$265K
- Ebon BourneMarietta$242K
- Jennifer WoehlerSavannah$207K
- Julian HutchinsGreensboro$201K
- Brian PearlmanDalton$199K
- Scott ParryAtlanta$162K
- Jennifer GilliganAtlanta$162K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.